Fasiplon

In this article we will talk about Fasiplon, a topic that has been the subject of interest and debate over the years. Fasiplon is a concept widely discussed in contemporary society, and its relevance has been manifested in different areas of study. From history to psychology, science and popular culture, Fasiplon has captured the attention of academics, experts and the general public. Throughout this article, we will explore the origins, meanings and repercussions of Fasiplon, as well as its impact on today's society.

Fasiplon
Clinical data
ATC code
  • none
Identifiers
  • 6-Ethyl-7-methoxy-5-methyl-2-(5-methyl-oxadiazol-3-yl)-imidazopyrimidine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H15N5O2
Molar mass273.296 g·mol−1
3D model (JSmol)
  • CC1=NC(C2=CN3C(N=C(OC)C(CC)=C3C)=N2)=NO1
  • InChI=1S/C13H15N5O2/c1-5-9-7(2)18-6-10(11-14-8(3)20-17-11)15-13(18)16-12(9)19-4/h6H,5H2,1-4H3 ☒N
  • Key:MEBYKPLMXIRYRQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.

Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action. It was developed by a team at Roussel Uclaf in the 1990s

References

  1. ^ Tully WR, Gardner CR, Gillespie RJ, Westwood R (July 1991). "2-(oxadiazolyl)- and 2-(thiazolyl)imidazopyrimidines as agonists and inverse agonists at benzodiazepine receptors". Journal of Medicinal Chemistry. 34 (7): 2060–7. doi:10.1021/jm00111a021. PMID 1648620.
  2. ^ US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
Wikious
Boobota
Sagapedia